Abstract:<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Background</h3><p>8-Hydroxyquinoline derivatives have highly sensitive fluorescent chemosensors for metal ions, which are associated with anti-oxidant, anti-tumor and anti-HIV-1 properties. Head and neck squamous cell carcinoma (HNSCC) is associated with a high rate of mortality and novel anti-HNSCC drugs must be developed. Therefore, effective chemotherapy agents are required to address this public health issue.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Hypothesis/Purpose</h3><p>The aim of this study was to investigate the inhibitory effect of tris(8-hydroxyquinoline)iron (Feq<sub>3</sub>) on the HNSCC and the underlying mechanism.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Study design/Methods</h3><p>A novel 8-hydroxyquinoline derivative, Feq<sub>3</sub>, was synthesized. The cell viabilities were analyzed using MTT reagent. Apoptosis and the cell cycle distributions were determined by flow cytometer. Reverse transcription-polymerase chain reaction (RT-PCR), immunofluorescence, western blot, MitoSOX and CellROX stain assay were used to study the mechanism of Feq<sub>3</sub>. Feq<sub>3</sub> combined with antioxidants NAC (<em>N</em>-acetylcysteine) and BSO (buthionine sulfoximine) measured the cell viability and intracellular ROS.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Results</h3><p>Feq<sub>3</sub> induced the death of HNSCC cells and caused them to exhibit the morphological features of apoptosis. Feq<sub>3</sub> also induced apoptosis of SCC9 cells by cell cycle arrest during the G<sub>2</sub>/M phase and the induced arrest of SCC25 cells in the G<sub>0</sub>/G<sub>1</sub> and G<sub>2</sub>/M phases, which was associated with decreased cyclin B1/cdc2 and cyclin D/cdk4 expressions. Feq<sub>3</sub> increases reactive oxygen species (ROS) and reduces glutathione (GSH) levels, and responds to increased p53 and p21 expressions. Feq<sub>3</sub> induced apoptosis by mitochondria-mediated Bax and cytochrome <em>c</em> up-expression and down-expression Bcl-2. Feq<sub>3</sub> also up-regulated tBid, which interacts with the mitochondrial pathway and tumor necrosis factor-α (TNF-α)/TNF-Rs, FasL/Fas, and TNF-related apoptosis inducing ligand receptors (TRAIL-Rs)/TRAIL-dependent caspases apoptotic signaling pathway in HNSCC cells. However, Feq<sub>3</sub> activates Fas but not FasL in SCC25 cells. Feq<sub>3</sub> arrests the growth of HNSCC cells and is involved in the mitochondria- and death receptor (DR)-mediated caspases apoptotic pathway.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Conclusion</h3><p>This study is the first to suggest that apoptosis mediates the anti-HNSCC of Feq<sub>3</sub>. Feq<sub>3</sub> has potential as a cancer therapeutic agent against HNSCC.</p>

RETRACTED: Thymoquinone sensitizes human hepatocarcinoma cells to TRAIL-induced apoptosis via oxidative DNA damage

Anti-liver Cancer Activity of TNF-related Apoptosis-Inducing Ligand Gene and Its Bystander Effects.

Erk phosphorylation reduces the thymoquinone toxicity in human hepatocarcinoma

[Synergistic Effects and Mechanisms of Combined Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand and Chemotherapeutic Drugs or Radiotherapy in Killing Laryngeal Squamous Carcinoma Cells in Vitro].

The Apoptotic Pathway of Laryngeal Squamous Carcinoma Cell Line Induced by Combined TRAIL with Chemotherapeutic Drugs or Radiotherapy

Thymoquinone Suppresses the Proliferation, Migration and Invasiveness through Regulating ROS, Autophagic Flux and miR-877-5p in Human Bladder Carcinoma Cells.

ABT-263 sensitizes TRAIL-resistant hepatocarcinoma cells by downregulating the Bcl-2 family of anti-apoptotic protein

Silencing thioredoxin induces liver cancer cell senescence under hypoxia.

Novel Insights into the Synergistic Interaction of a Thioredoxin Reductase Inhibitor and TRAIL: the Activation of the ASK1-ERK-Sp1 Pathway

Bortezomib Overcomes Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Resistance in Hepatocellular Carcinoma Cells in Part Through the Inhibition of the Phosphatidylinositol 3-Kinase/akt Pathway

Hepatocytes Treated With Hbv X Protein As Cytotoxic Effectors Kill Primary Hepatocytes By Tnf-Alpha-Related Apoptosis-Induced Ligand-Mediated Mechanism

Quercetin sensitizes human myeloid leukemia KG-1 cells against TRAIL-induced apoptosis

Calycosin-7-glucoside Promotes Mitochondria-Mediated Apoptosis in Hepatocellular Carcinoma by Targeting Thioredoxin 1 to Regulate Oxidative Stress.

β-Thujaplicin induces autophagic cell death, apoptosis, and cell cycle arrest through ROS-mediated Akt and p38/ERK MAPK signaling in human hepatocellular carcinoma

Chrysotoxene Induces Apoptosis of Human Hepatoblastoma HepG2 Cells Inï¿½vitro and Inï¿½vivo Via Activation of the Mitochondria-Mediated Apoptotic Signaling Pathway

Thymoquinone Induces G2/M Arrest, Inactivates PI3K/Akt and Nuclear Factor-Κb Pathways in Human Cholangiocarcinomas Both in Vitro and in Vivo.

Tumoricidal properties of thymoquinone on human colorectal adenocarcinoma cells via the modulation of autophagy

EV-T synergizes with AZD5582 to overcome TRAIL resistance through concomitant suppression of cFLIP, MCL-1, and IAPs in hepatocarcinoma

Tris(8-Hydroxyquinoline)iron induces apoptotic cell death via oxidative stress and by activating death receptor signaling pathway in human head and neck carcinoma cells

2-Tellurium-bridged Β-Cyclodextrin, a Thioredoxin Reductase Inhibitor, Sensitizes Human Breast Cancer Cells to TRAIL-induced Apoptosis Through DR5 Induction and NF-κB Suppression.

Notch1 Signaling Sensitizes Tumor Necrosis Factor-related Apoptosis-inducing Ligand-induced Apoptosis in Human Hepatocellular Carcinoma Cells by Inhibiting Akt/Hdm2-mediated P53 Degradation and Up-regulating P53-Dependent DR5 Expression*